Sort by
Refine Your Search
-
Listed
-
Field
-
, WES/WGS, targeted NGS, DigiWest), a broad spectrum of molecular and cellular biology techniques, biochemistry and biophysics, computational drug repurposing, and de novo design of novel protein-based
-
of nucleic acid sensing via cGAS/STING and RIG-like receptor pathways in hereditary inflammatory diseases culminating the development of therapeutically relevant drugs (Haag et al., 2018 Nature, Dressel et al
-
of nucleic acid sensing via cGAS/STING and RIG-like receptor pathways in hereditary inflammatory diseases culminating the development of therapeutically relevant drugs (Haag et al., 2018 Nature, Dressel et al
-
, computer-aided drug design or a related field. Track record of scientific innovation, as demonstrated by scientific publications, patents, relevant presentations, or software code. Demonstrated experience in
-
organism through production of bioactive secondary metabolites, ii) to identify their potential drug discovery against human diseases. Several microbial cultivation approaches, such as one-microbe-at-a-time
-
to publications and grant writing, and support the supervision of students and junior researchers in one the following research areas: Computational oncology AI drug discovery Statistical genetics, single-cell
-
the interplay of neurodegenerative diseases and aging, improve the early detection of affected individuals, and identify novel drug targets. Part of the work will be conducted within the international